{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:13:05Z","timestamp":1792678385705,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s00109-010-0704-4","type":"journal-article","created":{"date-parts":[[2010,11,30]],"date-time":"2010-11-30T10:57:49Z","timestamp":1291114669000},"page":"389-398","source":"Crossref","is-referenced-by-count":93,"title":["Readthrough of nonsense mutations in Rett syndrome: evaluation of novel aminoglycosides and generation of a new mouse model"],"prefix":"10.1007","volume":"89","author":[{"given":"Cornelia","family":"Brendel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valery","family":"Belakhov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hauke","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eike","family":"Wegener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jutta","family":"G\u00e4rtner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Nudelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timor","family":"Baasov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Huppke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,12,1]]},"reference":[{"key":"704_CR1","first-page":"723","volume":"116","author":"A Rett","year":"1946","unstructured":"Rett A (1946) On a unusual brain atrophy syndrome in hyperammonemia in childhood. Wien Med Wochenschr 116:723\u2013726","journal-title":"Wien Med Wochenschr"},{"key":"704_CR2","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1651-2227.1995.tb13809.x","volume":"84","author":"B Hagberg","year":"1995","unstructured":"Hagberg B (1995) Rett syndrome: clinical peculiarities and biological mysteries. Acta Paediatr 84:971\u2013976","journal-title":"Acta Paediatr"},{"key":"704_CR3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/13810","volume":"23","author":"RE Amir","year":"1999","unstructured":"Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23:185\u2013188","journal-title":"Nat Genet"},{"key":"704_CR4","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s003359900157","volume":"7","author":"M D\u2019Esposito","year":"1996","unstructured":"D\u2019Esposito M, Quaderi NA, Ciccodicola A, Bruni P, Esposito T, D\u2019Urso M, Brown SD (1996) Isolation, physical mapping, and northern analysis of the X-linked human gene encoding methyl CpG-binding protein, MECP2. Mamm Genome 7:533\u2013535","journal-title":"Mamm Genome"},{"key":"704_CR5","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/85899","volume":"27","author":"J Guy","year":"2001","unstructured":"Guy J, Hendrich B, Holmes M, Martin JE, Bird A (2001) A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 27:322\u2013326","journal-title":"Nat Genet"},{"key":"704_CR6","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/85906","volume":"27","author":"RZ Chen","year":"2001","unstructured":"Chen RZ, Akbarian S, Tudor M, Jaenisch R (2001) Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet 27:327\u2013331","journal-title":"Nat Genet"},{"key":"704_CR7","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0896-6273(02)00768-7","volume":"35","author":"M Shahbazian","year":"2002","unstructured":"Shahbazian M, Young J, Yuva-Paylor L, Spencer C, Antalffy B, Noebels J, Armstrong D, Paylor R, Zoghbi H (2002) Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 35:243\u2013254","journal-title":"Neuron"},{"key":"704_CR8","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/brain\/awl022","volume":"129","author":"GJ Pelka","year":"2006","unstructured":"Pelka GJ, Watson CM, Radziewic T, Hayward M, Lahooti H, Christodoulou J, Tam PP (2006) Mecp2 deficiency is associated with learning and cognitive deficits and altered gene activity in the hippocampal region of mice. Brain 129:887\u2013898","journal-title":"Brain"},{"key":"704_CR9","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1126\/science.1138389","volume":"315","author":"J Guy","year":"2007","unstructured":"Guy J, Gan J, Selfridge J, Cobb S, Bird A (2007) Reversal of neurological defects in a mouse model of Rett syndrome. Science 315:1143\u20131147","journal-title":"Science"},{"key":"704_CR10","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1177\/0883073807308715","volume":"22","author":"AK Percy","year":"2007","unstructured":"Percy AK, Lane JB, Childers J, Skinner S, Annese F, Barrish J, Caeg E, Glaze DG, MacLeod P (2007) Rett syndrome: North American database. J Child Neurol 22:1338\u20131341","journal-title":"J Child Neurol"},{"key":"704_CR11","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1203\/PDR.0b013e31819d9ebc","volume":"65","author":"C Brendel","year":"2009","unstructured":"Brendel C, Klahold E, Gartner J, Huppke P (2009) Suppression of nonsense mutations in Rett syndrome by aminoglycoside antibiotics. Pediatr Res 65:520\u2013523","journal-title":"Pediatr Res"},{"key":"704_CR12","doi-asserted-by":"crossref","unstructured":"Popescu AC, Sidorova E, Zhang G and Eubanks JH Aminoglycoside-mediated partial suppression of MECP2 nonsense mutations responsible for Rett syndrome in vitro. Journal of neuroscience research 88: 2316\u20132324","DOI":"10.1002\/jnr.22409"},{"key":"704_CR13","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1021\/jm801640k","volume":"52","author":"I Nudelman","year":"2009","unstructured":"Nudelman I, Rebibo-Sabbah A, Cherniavsky M, Belakhov V, Hainrichson M, Chen F, Schacht J, Pilch DS, Ben-Yosef T, Baasov T (2009) Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations. J Med Chem 52:2836\u20132845","journal-title":"J Med Chem"},{"key":"704_CR14","doi-asserted-by":"crossref","unstructured":"Nudelman I, Glikin D, Smolkin B, Hainrichson M, Belakhov V and Baasov T Repairing faulty genes by aminoglycosides: development of new derivatives of geneticin (G418) with enhanced suppression of diseases-causing nonsense mutations. Bioorg Med Chem 18: 3735\u20133746","DOI":"10.1016\/j.bmc.2010.03.060"},{"key":"704_CR15","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/(SICI)1097-4547(19971201)50:5<829::AID-JNR19>3.0.CO;2-W","volume":"50","author":"S Forss-Petter","year":"1997","unstructured":"Forss-Petter S, Werner H, Berger J, Lassmann H, Molzer B, Schwab MH, Bernheimer H, Zimmermann F, Nave KA (1997) Targeted inactivation of the X-linked adrenoleukodystrophy gene in mice. J Neurosci Res 50:829\u2013843","journal-title":"J Neurosci Res"},{"key":"704_CR16","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1093\/carcin\/bgg163","volume":"24","author":"F Esfandiari","year":"2003","unstructured":"Esfandiari F, Green R, Cotterman RF, Pogribny IP, James SJ, Miller JW (2003) Methyl deficiency causes reduction of the methyl-CpG-binding protein, MeCP2, in rat liver. Carcinogenesis 24:1935\u20131940","journal-title":"Carcinogenesis"},{"key":"704_CR17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2165\/00063030-200923030-00003","volume":"23","author":"SM Rowe","year":"2009","unstructured":"Rowe SM, Clancy JP (2009) Pharmaceuticals targeting nonsense mutations in genetic diseases: progress in development. BioDrugs 23:165\u2013174","journal-title":"BioDrugs"},{"key":"704_CR18","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/ana.1023","volume":"49","author":"KR Wagner","year":"2001","unstructured":"Wagner KR, Hamed S, Hadley DW, Gropman AL, Burstein AH, Escolar DM, Hoffman EP, Fischbeck KH (2001) Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations. Ann Neurol 49:706\u2013711","journal-title":"Ann Neurol"},{"key":"704_CR19","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ana.22024","volume":"67","author":"V Malik","year":"2010","unstructured":"Malik V, Rodino-Klapac LR, Viollet L, Wall C, King W, Al-Dahhak R, Lewis S, Shilling CJ, Kota J, Serrano-Munuera C et al (2010) Gentamicin-induced readthrough of stop codons in Duchenne muscular dystrophy. Ann Neurol 67:771\u2013780","journal-title":"Ann Neurol"},{"key":"704_CR20","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1164\/ajrccm.163.7.2004001","volume":"163","author":"JP Clancy","year":"2001","unstructured":"Clancy JP, Bebok Z, Ruiz F, King C, Jones J, Walker L, Greer H, Hong J, Wing L, Macaluso M et al (2001) Evidence that systemic gentamicin suppresses premature stop mutations in patients with cystic fibrosis. Am J Respir Crit Care Med 163:1683\u20131692","journal-title":"Am J Respir Crit Care Med"},{"key":"704_CR21","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1056\/NEJMoa022170","volume":"349","author":"M Wilschanski","year":"2003","unstructured":"Wilschanski M, Yahav Y, Yaacov Y, Blau H, Bentur L, Rivlin J, Aviram M, Bdolah-Abram T, Bebok Z, Shushi L et al (2003) Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations. N Engl J Med 349:1433\u20131441","journal-title":"N Engl J Med"},{"key":"704_CR22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000013861","volume":"5","author":"A Forge","year":"2000","unstructured":"Forge A, Schacht J (2000) Aminoglycoside antibiotics. Audiol neuro otol 5:3\u201322","journal-title":"Audiol neuro otol"},{"key":"704_CR23","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1128\/AAC.43.5.1003","volume":"43","author":"MP Mingeot-Leclercq","year":"1999","unstructured":"Mingeot-Leclercq MP, Tulkens PM (1999) Aminoglycosides: nephrotoxicity. Antimicrob Agents Chemother 43:1003\u20131012","journal-title":"Antimicrob Agents Chemother"},{"key":"704_CR24","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1016\/j.bmc.2010.03.060","volume":"18","author":"I Nudelman","year":"2010","unstructured":"Nudelman I, Glikin D, Smolkin B, Hainrichson M, Belakhov V, Baasov T (2010) Repairing faulty genes by aminoglycosides: development of new derivatives of geneticin (G418) with enhanced suppression of diseases-causing nonsense mutations. Bioorg Med Chem 18:3735\u20133746","journal-title":"Bioorg Med Chem"},{"key":"704_CR25","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/FBP.0b013e32830c3645","volume":"19","author":"L Ricceri","year":"2008","unstructured":"Ricceri L, De Filippis B, Laviola G (2008) Mouse models of Rett syndrome: from behavioural phenotyping to preclinical evaluation of new therapeutic approaches. Behav Pharmacol 19:501\u2013517","journal-title":"Behav Pharmacol"},{"key":"704_CR26","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00109-006-0045-5","volume":"84","author":"M Du","year":"2006","unstructured":"Du M, Keeling KM, Fan L, Liu X, Kovacs T, Sorscher E, Bedwell DM (2006) Clinical doses of amikacin provide more effective suppression of the human CFTR-G542X stop mutation than gentamicin in a transgenic CF mouse model. J Mol Med (Berlin, Germany) 84:573\u2013582","journal-title":"J Mol Med (Berlin, Germany)"},{"key":"704_CR27","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00439-007-0410-7","volume":"122","author":"A Rebibo-Sabbah","year":"2007","unstructured":"Rebibo-Sabbah A, Nudelman I, Ahmed ZM, Baasov T, Ben-Yosef T (2007) In vitro and ex vivo suppression by aminoglycosides of PCDH15 nonsense mutations underlying type 1 Usher syndrome. Hum Genet 122:373\u2013381","journal-title":"Hum Genet"},{"key":"704_CR28","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/1531-8249(200008)48:2<164::AID-ANA5>3.0.CO;2-B","volume":"48","author":"MT Howard","year":"2000","unstructured":"Howard MT, Shirts BH, Petros LM, Flanigan KM, Gesteland RF, Atkins JF (2000) Sequence specificity of aminoglycoside-induced stop condon readthrough: potential implications for treatment of Duchenne muscular dystrophy. Ann Neurol 48:164\u2013169","journal-title":"Ann Neurol"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s00109-010-0704-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T16:22:14Z","timestamp":1711988534000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-010-0704-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,1]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["704"],"URL":"https:\/\/doi.org\/10.1007\/s00109-010-0704-4","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,1]]}}}